Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Sezary Syndrome 1 Osteosarcoma 1 Neuroblastoma 1 Mycosis Fungoides 1 Leukemia, Myeloid, Acute 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1

Interventions

Radiosurgery 51 Magnetic Resonance Spectroscopy 34 Temozolomide 28 pembrolizumab 24 Bevacizumab 24 Radiotherapy 20 Nivolumab 20 Specimen Handling 14 Ipilimumab 13 Cyclophosphamide 13 Mental Status and Dementia Tests 12 Carboplatin 12 abemaciclib 10 Radiation 10 Blood Specimen Collection 9 trastuzumab deruxtecan 8 Proton Therapy 7 Pemetrexed 7 Memantine 7 fluciclovine F-18 6 binimetinib 6 Paclitaxel 6 Etoposide 6 Cisplatin 6 Capecitabine 6 encorafenib 5 Trastuzumab 5 Surveys and Questionnaires 5 Surgical Procedures, Operative 5 Lomustine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × magrolimab × 1 year × Clear all

NCT05169944 2025-07-09

PNOC025

University of California, San Francisco

Phase 1 Completed

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡